Stocks · News reference
AchieveRx Reports Third Quarter 2026 Financial Results
AchieveRx, formerly Achieve Life Sciences, reported its financial results for the third quarter of 2026 and provided updates on its clinical and commercial progress.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Achieve Life Sciences Q3 EPS $(11.00) Misses $(0.20) Estimate
Achieve Life Sciences Announces Rebranding to AchieveRx and Ticker Symbol Change
Achieve Life Sciences, Inc. has rebranded as AchieveRx™, The Quit Company™, and will transition its Nasdaq ticker symbol to 'QUIT' effective November 10, 2026.
Achieve Life Sciences Announces Stock Option and RSU Grants for New Employees
Achieve Life Sciences, Inc. announced that its Board of Directors' Compensation Committee approved equity awards for three new employees.
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
Achieve Life Sciences presented 52-week data for its cytisinicline program, which is being developed as a treatment for nicotine dependence, at the CHEST 2026 annual meeting.
Achieve Life Sciences Presents 52-Week Cytisinicline Results From ORCA-OL Clinical Trial At CHEST 2026